Evaluating new multiple sclerosis (MS) treatments is challenging due to diagnostic and assessment limitations. These inherent difficulties in MS research necessitate careful statistical methods and randomized trials for reliable therapeutic evaluation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: